List of works - Nicolas Vuilleumier

Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome.

scientific article published on 25 January 2011

Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes

scientific article published on 4 August 2016

Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques

scientific article published on 19 October 2020

Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability

Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4

article published in 2015

Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.

scientific article

Antiapolipoprotein A-1 Autoantibody Positivity Is Associated with Threatened Abortion

scientific article published on 07 March 2020

Atherosclerotic plaque vulnerability is increased in mouse model of lupus

scientific article published on 27 October 2020

Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases

scientific article published on January 2014

Commentary on a previous review article published by Kim SY et al

scientific article published on 26 February 2020

Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways.

scientific article published on 21 October 2014

Inferior vena cava parameters predict re-admission in ischaemic heart failure

Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction

scientific article published on 14 May 2012

Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis

scientific article published on 21 September 2016

Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case

scientific article published on January 2014

Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.

scientific article published on 7 November 2013

Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2

scientific article

Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

scientific article

Prognostic value of PCSK9 levels in patients with acute coronary syndromes

scientific article

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

scientific article published on 24 November 2011

Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy

scholarly article by Giovanni Spinella et al published 2013 in Thrombosis and Haemostasis

Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke

scientific article published on 24 April 2015

Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.

scientific article

The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.

scientific article

Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis

scientific article

Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response.

scientific article published on 25 April 2015

Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways

scientific article published on 18 December 2014

Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice

scientific article

Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis.

scientific article published on 28 November 2013

Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages

scientific article published on 20 August 2016

List of works by Nicolas Vuilleumier

Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome.

Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes

Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques

Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability

Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4

Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.

Antiapolipoprotein A-1 Autoantibody Positivity Is Associated with Threatened Abortion

Atherosclerotic plaque vulnerability is increased in mouse model of lupus

Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases

Commentary on a previous review article published by Kim SY et al

Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways.

Inferior vena cava parameters predict re-admission in ischaemic heart failure

Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction

Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis

Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case

Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.

Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2

Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

Prognostic value of PCSK9 levels in patients with acute coronary syndromes

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy

Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke

Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis.

The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.

Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis

Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response.

Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways

Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice

Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis.

Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages